Collaboration Agreement to Share Best Practices for Improved Cancer Treatment
By MedImaging International staff writers Posted on 23 Mar 2015 |
The World Molecular Imaging Society (WMIS; Culver City, CA, USA) and the US National Cancer Institute (NCI; Rockville, MD, USA) have announced that they will begin collaborating to promote best practices for the treatment of cancer and other diseases. The clinical goals of the collaboration are to establish effective mouse/human co-clinical therapy and prevention trials.
The two institutes will cooperate on best practices for co-clinical trials of combination therapy in patients and mice, and for quantitative imaging and imaging protocols for mouse and human-in-mouse models of appropriate genotypes representing patients. The collaboration should improve the correlation of prospective and/or retrospective clinical trial data, with the results from the mouse models.
Hedvig Hricak MD, PhD, chairman, department of radiology, Memorial Sloan-Kettering Cancer, member of WMIS, said, "Molecular imaging and the emerging field of theranostics are essential to the successful implementation of precision medicine. The World Molecular Imaging Society, with its international forum for discussing all aspects of molecular imaging and related fields, is in a unique position to take the lead in global discussion, innovation and scientific collaboration, from preclinical studies to first-in-human imaging trials."
Related Links:
WMIS
NCI
The two institutes will cooperate on best practices for co-clinical trials of combination therapy in patients and mice, and for quantitative imaging and imaging protocols for mouse and human-in-mouse models of appropriate genotypes representing patients. The collaboration should improve the correlation of prospective and/or retrospective clinical trial data, with the results from the mouse models.
Hedvig Hricak MD, PhD, chairman, department of radiology, Memorial Sloan-Kettering Cancer, member of WMIS, said, "Molecular imaging and the emerging field of theranostics are essential to the successful implementation of precision medicine. The World Molecular Imaging Society, with its international forum for discussing all aspects of molecular imaging and related fields, is in a unique position to take the lead in global discussion, innovation and scientific collaboration, from preclinical studies to first-in-human imaging trials."
Related Links:
WMIS
NCI
Latest Nuclear Medicine News
- New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment